Rosuvastatin Completed Phase 3 Trials for Heart Failure Prevention

IndicationsStatusPurposePhase
CompletedPrevention3
clinicaltrials.gov IdentifierTitleDrugs
NCT00206310Crestor Versus Placebo in Subjects With Heart Failure